News & Updates

Show Multimedia Only

Cancer patients report high acceptance of telemedicine

14 Jun 2022 by

Patients with cancer are not averse to telemedicine, reporting satisfaction with their experience, according to a Singapore study. This high acceptance is associated with facilitating conditions such as having necessary resources and perceived improved access.

14 Jun 2022

Beta-blocker use reduces daily physical activity

14 Jun 2022

Treatment with beta-blockers in hypertension may decrease daily physical activity but not maximal exercise performance, a study has found.

14 Jun 2022

Higher dairy intake tied to lower T2D risk

14 Jun 2022 by

Higher consumption of dairy products is associated with a lower risk of type 2 diabetes (T2D) among US adults, according to a nationally representative study presented at ADA 2022.

14 Jun 2022

Autoantibodies against type 1 interferons increase COVID-19 death risk

14 Jun 2022 by

The presence of autoantibodies neutralizing type 1 interferons (IFN), such as IFN-α2 or IFN-ω, strongly increase the relative risk of death (RRD) and infection fatality rate (IFR) in unvaccinated patients with COVID-19, according to a recent study.

14 Jun 2022

Amiodarone use may reduce survival in continuous‐flow left ventricular assist device recipients

14 Jun 2022

For patients who have undergone continuous‐flow left ventricular assist device (CF‐LVAD) implantation, treatment with amiodarone may do more harm than good, with a recent study showing that it contributes to increased risk of mortality.

14 Jun 2022

Playing a musical instrument boosts brain blood flow

14 Jun 2022

For musicians, playing a musical instrument appears to increase blood flow velocity in the middle cerebral artery (MCAv), a recent study has found.

14 Jun 2022

Prophylactic 5-FU plus heparin not effective against proliferative vitreoretinopathy in RRD

14 Jun 2022

Adjuvant therapy with 5-fluorouracil (5-FU) and low molecular weight heparin in high-risk patients with rhegmatogenous retinal detachment (RRD) does not help prevent the development of proliferative vitreoretinopathy, as shown in a study.

14 Jun 2022

Treatment outcomes for nAMD, DMO, RVO poorer in clinical practice than in trials

13 Jun 2022

In clinical practice, patients with neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), and retinal vein occlusion (RVO) see treatment outcomes that are inferior to those reported in pivotal phase 3 studies, according to a recent study.